[HTML][HTML] Colorectal cancer growth retardation through induction of apoptosis, using an optimized synergistic cocktail of axitinib, erlotinib, and dasatinib
RH Berndsen, N Swier, JR van Beijnum… - Cancers, 2019 - mdpi.com
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
[PDF][PDF] Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
RH Berndsen, N Swier, JR van Beijnum… - pdfs.semanticscholar.org
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
RH Berndsen, N Swier, JR van Beijnum… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.
RH Berndsen, N Swier, JR van Beijnum… - Cancers, 2019 - sonar.ch
English Patients with advanced colorectal cancer (CRC) still depend on chemotherapy
regimens that are associated with significant limitations, including resistance and toxicity …
regimens that are associated with significant limitations, including resistance and toxicity …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.
RH Berndsen, N Swier, JR van Beijnum… - Cancers, 2019 - europepmc.org
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.
RH Berndsen, N Swier, JR van Beijnum… - …, 2019 - search.ebscohost.com
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib.
RH Berndsen, N Swier, JR van Beijnum… - Cancers, 2019 - folia.unifr.ch
English Patients with advanced colorectal cancer (CRC) still depend on chemotherapy
regimens that are associated with significant limitations, including resistance and toxicity …
regimens that are associated with significant limitations, including resistance and toxicity …
Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
RH Berndsen, N Swier, JR van Beijnum… - …, 2019 - search.proquest.com
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
[PDF][PDF] Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
RH Berndsen, N Swier, JR van Beijnum… - access.archive-ouverte.unige.ch
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …
[HTML][HTML] Colorectal Cancer Growth Retardation through Induction of Apoptosis, Using an Optimized Synergistic Cocktail of Axitinib, Erlotinib, and Dasatinib
RH Berndsen, N Swier, JR van Beijnum… - Cancers, 2019 - ncbi.nlm.nih.gov
Patients with advanced colorectal cancer (CRC) still depend on chemotherapy regimens
that are associated with significant limitations, including resistance and toxicity. The …
that are associated with significant limitations, including resistance and toxicity. The …